PMGC HOLDINGS INC. (ELAB)
NorthStrive Biosciences Signs Licensing Agreement Amendment with MOA Life Plus [KOSDAQ: 142760] for Dual Myostatin Assets Targeting Muscle Preservation in Combination with GLP-1 Treatments
NorthStrive Biosciences Signs Licensing Agreement Amendment with MOA Life Plus [KOSDAQ: 142760] for Dual Myostatin Assets Targeting Muscle Preservation in Combination with GLP-1 Treatments
SPAR Group, Inc. Announces Timing of Fiscal 2025 Fourth Quarter and Full Year Results Conference Call
Fastenal Company Announces Conference Call to Review 2026 First Quarter Earnings
FiEE, Inc. to Invest Approximately $3.0 Million to Build AI Music Ecosystem
Innoviz Announces Receipt of Nasdaq Non-Compliance Letter
Presurance Holdings Reports 2025 Fourth Quarter Financial Results
Immersion Corporation Receives Nasdaq Staff Additional Delinquency Notice
Health In Tech Announces Closing of $7.0 Million Private Placement
Dawson Geophysical to Issue Fourth Quarter and Year End 2025 Results and Hold Investor Conference Call
Quanterix Corporation Announces Date of 2026 Annual Meeting